Dr
Richard
Williams

Experience

Richard has more than 30 years continuous working experience in private practice. He has encountered a broad and varied spectrum of possible situations and scenarios involving all sorts of IP challenges and requirements.

Certain essential elements of patent work align well with Richard's character. He enjoys the sense of chase he gets in fact finding and "stone turning". This means Richard is very adept at peeling back the layers of any matter to get quickly to the heart of it, legally, technically and commercially. He also has a particularly well-honed radar for identifying risk and opportunity, and then a creative imperative and internal driver to match. Richard finds the combinations of these skills serves him well in generating excellent cost effective commercial solutions to whatever patent challenges he is presented with.

Broadly, Richard's technical knowledge and experience comes under IPC codes: A01, A21, A22, A23, A24, A61, B01, B09, B82, C02, C04, C11, C12 (C12N, C12 Q), C13, C25 and C40.

More specifically: CRISPR; gene editing; riboswitches, nucleic acid sequencing; PCR based assays; nucleic acid-based diagnostics; antibodies (therapeutic or diagnostic), immunoaffinity purification; chimeric T cells and therapies; miRNA, siRNA, oncology; biomarkers; bioinformatics; enzymes; epigenetics; modified bacteria, viruses, algae, fungi, plants, insects (mosquitoes), fish and fish feed, animals, plant secondary compounds; oligosaccharides; pest control; plant breeding tools; plant protection products; biodegradable packaging; sewage treatments; human pharmaceutical formulations (small molecules, proteins, antibodies); vaccines (anticancer, influenza); medical devices; ocular devices, diagnostics and therapies.